Semaglutide cancer and depression risks investigation

Concerns Ozempic ingredient may be related to thyroid cancer and suicide ideation draws attention of EMA Semaglutide, the active ingredient in hyped diabetes and weight loss drug, Ozempic and others, has been flagged as potentially increasing the risk of thyroid cancer and, separately, of causing suicidal thoughts. The dual scares come as supplies of Ozempic